Pharmaxis Ltd reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported revenue was AUD 8.08 million compared to AUD 5.89 million a year ago. Net income was AUD 0.943 million compared to net loss of AUD 3.03 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 AUD | -4.35% |
|
-15.38% | +10.00% |
13/06 | Transcript : Syntara Limited Presents at MST Access 'Hidden Gems in Life Sciences' Webinar, Jun-13-2024 02:30 PM | |
30/04 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 17.45M | |
+55.95% | 819B | |
+44.25% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+16.83% | 242B | |
+2.58% | 225B | |
+13.09% | 217B | |
+8.91% | 168B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Ltd Reports Earnings Results for the First Quarter Ended September 30, 2022